Skip to main content
Veterinary Medicines

ACTI-STREPTO

Authorised
  • Dihydrostreptomycin sulfate

Identifikacija zdravila

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    626.00
    milligram(s)
    /
    1.00
    gram(s)
Farmacevtska oblika:
  • Prašek za peroralno raztopino
Withdrawal period by route of administration:
  • Oral use
    • govedo
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        14
        day
    • Rabbit
      • Meat and offal
        14
        day
    • tele
      • Meat and offal
        14
        day
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QA07AA90
Status dovoljenja:
  • Valid
Authorised in:
  • France
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Laboratoires Biove
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Laboratoires Biové
Pristojni organ:
  • French Agency For Food, Environmental And Occupational Health & Safety
Številka dovoljenja :
  • FR/V/2441413 9/1992
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
French (PDF)
Objavljeno na: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."